• Combination of anti-HER2 breast cancer therapy and checkpoint inhibitor provides no benefit

    1 month ago - By News Medical

    Adding an immune checkpoint inhibitor to anti-HER2 treatment in breast cancer does not improve pathological complete response , according to the primary analysis of the IMpassion050 trial presented today during the ESMO Virtual Plenary.
    Read more ...